U3 PHARMA
U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Professor Axel Ullrich. Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.
U3 PHARMA
Industry:
Biotechnology Health Care
Founded:
2001-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.u3pharma.com
Total Employee:
11+
Status:
Active
Total Funding:
50.77 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome Sitelinks Search Box Yoast WordPress SEO Plugin Nginx Person Schema
Similar Organizations
Arpida AG
Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.
Hamlet Pharma
Hamlet Pharma is a pharmaceutical company with strong links to research.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Founder
Investors List
Atlas Venture
Atlas Venture investment in Venture Round - U3 Pharma
LSP BioVentures
LSP BioVentures investment in Venture Round - U3 Pharma
Alta Partners
Alta Partners investment in Venture Round - U3 Pharma
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity investment in Venture Round - U3 Pharma
Bio*One Capital
Bio*One Capital investment in Venture Round - U3 Pharma
LCF Rothschild
LCF Rothschild investment in Venture Round - U3 Pharma
Atlas Venture
Atlas Venture investment in Venture Round - U3 Pharma
BioM Venture Capital
BioM Venture Capital investment in Venture Round - U3 Pharma
Official Site Inspections
http://www.u3pharma.com Semrush global rank: 9.5 M Semrush visits lastest month: 369
- Host name: 14.225.238.143
- IP address: 14.225.238.143
- Location: Vietnam
- Latitude: 16.0023
- Longitude: 105.9999
- Timezone: Asia/Ho_Chi_Minh
More informations about "U3 Pharma"
U3 Pharma - Crunchbase Company Profile & Funding
U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel …See details»
U3 Pharma Company Profile | Management and Employees List
[email protected]: 4: first_last: [email protected]: 5: first: [email protected]: Your Questions, Our Answers Get Free Access to U3 Pharma …See details»
U3 Pharma - Products, Competitors, Financials, Employees, …
In addition, U3 Pharma has created a second-generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant …See details»
U3 Pharma AG - life-sciences-europe.com
Jul 1, 2001 https://www.u3pharma.com U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the …See details»
U3 Pharma AG - Drug pipelines, Patents, Clinical trials - Synapse
Www.u3pharma.com. Subsidiary Company | 2001 | Germany | 10-50 | www.u3pharma.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»
U3 Pharma GmbH - Martinsried, Germany - bionity.com
We are a clinical-stage biopharmaceutical company developing protein therapeutics for the treatment of diseases with serious unmet need, primarily cancer. We were founded in 2001 by …See details»
U3 Pharma - Overview, News & Similar companies | ZoomInfo.com
Who is U3 Pharma. U3 Pharma AG is a biopharmaceutical company focused on the creation of novel therapeutic products that specifically target key components of cellul ar signal …See details»
U3 Pharma - Company Profile - Tracxn
Feb 24, 2025 Email ID: *****@u3pharma.com; Key Metrics. Total Funding. $49.2M in 2 rounds. Latest Funding Round. Series C, May 22, 2006, $34.5M. Investors. Life Sciences Partners & 5 …See details»
U3 Pharma AG | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
U3 Pharma - Crunchbase
U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug development.See details»
Trang chuyên tin tức về hướng dẫn sử dụng các loại thuốc an toàn …
U3pharma.Com – Website hàng đầu về các tin tức y tế trong và ngoài nước, cung cấp thông tin về các loại thuốc y dược, các bệnh thường gặp, mẹo vặt điều trị bệnh,… và nhiều thông tin …See details»
U3 Pharma Profil | German Science Day
Www.u3pharma.com. U3 Pharma. Die U3 Pharma GmbH ist ein führendes Unternehmen in der Entwicklung von innovativen Krebs-Antikörpern. Auf Basis der Entdeckungen des …See details»
U3 Pharma - Products, Competitors, Financials, Employees, …
U3pharma.com. Overview & Products; About U3 Pharma. U3 Pharma is a clinical-stage biopharmaceutical company focused on developing protein therapeutics for the treatment of …See details»
U3 Pharma GmbH - discovery.patsnap.com
Discovery Company profile page for U3 Pharma GmbH including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
U3 Pharma Raises Euro 27 Million (US $34M) In Third Round Of
May 22, 2006 For more information: U3 Pharma AG Dr. Edward Stuart Managing Director, CBO +49 (0)171 493 8881 [email protected] Gretchen L.P. Schweitzer +49 (0)89 450 29741 …See details»
U3 Pharma - Overview, News & Competitors | ZoomInfo.com
U3 Pharma. Manufacturing · Viet Nam · 48 Employees. U3 Pharma AG is a biopharmaceutical company focused on the creation of novel therapeutic products that specifically target key …See details»
U3 Pharma (sold to Daiichi Sankyo) - VentureRadar
Similar Companies: QAtor Denmark Privately Held QAtor is a global software firm specialising in compliance and Quality Assurance software for the Life Sciences Industry. The company has …See details»
U3 Pharma - Funding, Financials, Valuation & Investors - Crunchbase
U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug development.See details»
Daiichi Sankyo to close research subsidiary U3 Pharma - Drug …
Dec 1, 2015 Daiichi Sankyo Company has announced its decision to close its research subsidiary, U3 Pharma GmbH.. U3 Pharma is a clinical-stage biopharmaceutical company …See details»
Daiichi Sankyo to acquire U3 Pharma for $233.5 million
May 21, 2008 TOKYO and LONDON Daiichi Sankyo has agreed to purchase the German biotech company U3 Pharma for $233.5 million, in an effort to boost its cancer drug pipeline, …See details»